✦ LIBER ✦

Altered energy coupling in rat heart mitochondria following in vivo treatment with propranolol

✍ Scribed by Surendra S Katyare; Rema R Rajan

Book ID: 115782209
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 878 KB
Volume: 42
Category: Article
ISSN: 0006-2952
DOI: 10.1016/0006-2952(91)90325-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Altered synaptosomal ATPase activity in

Altered synaptosomal ATPase activity in rat brain following prolonged in vivo treatment with nicotine

✍ Joshua M. Shallom; Surendra S. Katyare 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 394 KB

Altered Cerebral Protein Turnover in Rat

Altered Cerebral Protein Turnover in Rats Following Prolonged In Vivo Treatment with Nicotine

✍ Surendra S. Katyare; Joshua M. Shallom 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Alterations of mitochondria in liver but

Alterations of mitochondria in liver but not in heart homogenates after treatment of rats with benznidazole

✍ Rendon, D. 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 167 KB

Alteration of energy-linked functions in

Alteration of energy-linked functions in rat hepatic mitochondria following aflatoxin B1 administration

✍ Sajan, M. P. ;Satav, J. G. ;Bhattacharya, R. K. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Effect of long-term in vivo treatment wi

Effect of long-term in vivo treatment with imipramine on the oxidative energy metabolism in rat brain mitochondria

✍ Surendra S. Katyare; Rema R. Rajan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 494 KB

Effect of altered AGP plasma binding on

Effect of altered AGP plasma binding on heart rate changes by S(−)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (KB,vivo)

✍ T.J. van Steeg; E.H.J. Krekels; J. Freijer; M. Danhof; E.C.M. de Lange 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

In contrast to the impact of plasma protein binding on pharmacokinetics, no quantitative in vivo information is available on its impact on pharmacodynamics. The pharmacokinetic-pharmacodynamic relationship of the model drug S(À)-propranolol was evaluated using mechanism-based estimations of in vivo